| Monday 8 April 2019 | |
| Full day pre-congress workshop | |
| An interactive case study master class for the treatment of axial spondyloarthropathy led by Australian and European experts
Time: 0900-1700
Room: P5 Click here for more details
|
|
| Half day pre-congress workshop | Half day pre-congress workshop |
| Navigating the Vessel of Vasculitis
Time: 1330-1700
Room: P6 Click here for more details
|
Clinical Case Series in Spondyloarthropathies
Time: 1330-1700
Room: P7 Click here for more details.
|
| Tuesday 9 April 2019 | |||
| Morning symposium | Morning symposium | Morning symposium | Morning symposium |
|
Time: 1030-1145
Room: Great Hall
|
A new treatment option for PsA patients
Time: 1030-1145
Room: M1 & M2 Click here for more details.
|
OSTEOPOROSIS TREATMENTS: starting, sequencing and stopping – what is the long-term outlook?
Time: 1030-1145
Room: P1 & P2 Click here for more details.
|
Rheum for Improvement? The increasing role of RWE in decision making |
| Lunch symposium | |||
| Stay ahead of the game – Future approaches to spondyloarthropathies
Time: 1300-1430
Room: Great Hall Click here for more details
|
|||
| Evening symposium | |||
| Breaking New Ground in Rheumatology: We Haven’t Come This Far, to Only Come This Far
Time: 1755-1855
Room: P1 & P2 + P3, P4, & P5 Click here for more details
|
|||
| Wednesday 10 April 2019 | ||
| Morning symposium | Morning symposium | Morning symposium |
|
Time: 1030-1145
Room: M1 & M2
|
Redefining your practice with infliximab biosimilar
Time: 1030-1145
Room: P1 & P2 Click here for more details.
|
The spondyloarthritides – new data, more options, evolved thinking – what’s in it for the patient?
Time: 1030-1145
Room: P3, P4 & P5 Click here for more details.
|
| Lunch Symposium | ||
| Pathways to better outcomes in rheumatic disease
Time: 1300-1430
Room: Great Hall Click here for more details.
|
||
| Thursday 11 April 2019 | ||
| Lunch Symposium | ||
| The Management of Axial Spondyloarthritis – New advances and challenges
Time: 1230-1400
Room: Great Hall Click here for more details.
|